Effective treatments for chronic spinal pain are essential to reduce the related high personal and socioeconomic costs.
N onspecific chronic spinal pain (nCSP) is associated with significant health care use and high rates of disability worldwide. 1 Currently, nonsurgical treatments for nCSP, including nonsteroidal anti-inflammatory drugs, joint manipulation, acupuncture, and exercise therapy, seem to have limited benefits (small to moderate effect sizes). 2 This finding may be explained by the fact that such treatments do not comply with recent advances in chronic pain research. These recent advances suggest hyperexcitability of the central nervous system, including malfunctioning of descending nociceptive inhibition, and gray matter morphologic changes in people with nCSP. [3] [4] [5] These brain alterations-with a trend toward decreased gray matter volume-are reported in regions involved in modulatory, emotional-affective, and sensory-discriminative pain processing. 4 More important, these morphologic changes are suggested to be reversible in response to successful treatment. 6 However, to our knowledge, controlled clinical studies investigating this outcome in people with nCSP are currently lacking. Individuals with nCSP also tend to have inappropriate pain cognitions associated with poor treatment outcome, such as kinesiophobia, hypervigilance, and pain catastrophizing. [7] [8] [9] As with the changes in gray matter morphology, current treatment of nCSP does not account for inappropriate pain cognitions. 2 Therefore, a treatment addressing both gray matter morphologic findings and inappropriate pain cognitions might result in larger effect sizes and clinically relevant changes. Such an approach (ie, combined pain neuroscience education with cognition-targeted exercise therapy) has previously been investigated in a pilot study with 1 year of follow-up, including a small sample of people with chronic low back pain. 10 The reductions in pain and disability were high, but that study did not include a comparison with current best-evidence physiotherapy and did not include individuals with chronic neck pain, despite the similarities in underlying pain mechanisms between people with neck pain and those with low back pain.
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Based on the above-described voids, this sufficiently powered, multicenter randomized clinical trial investigated whether pain neuroscience education combined with cognition-targeted motor control training is superior to current best-evidence physiotherapy in reducing pain and improving functionality, gray matter morphologic features, and pain cognitions in individuals with nCSP.
Methods

Design
Data were collected from January 1, 2014, to January 30, 2017, in the University Hospitals of Ghent and Brussels in Belgium. This study was approved by the ethics committees of the University Hospital of Ghent (2013/1133) and Brussels (2013/385). Participants provided written informed consent. A detailed study protocol has been published 12 (see also study protocol in Supplement 1).
Blinding
The study participants, statistician, and outcomes assessors were blinded (triple-blind study). Participants did not meet in the waiting rooms (no contamination).
Study Population and Sample Size
Participants were recruited through flyers distributed to the university hospitals and universities, occupational health services, and primary care practices and via social media and advertisements. Inclusion criteria were as follows: native Dutch speaking, 18 to 65 years of age, and having nCSP (≥3 days per week and ≥3months of chronic low back pain, failed back surgery syndrome >3 year prior, chronic whiplash, or chronic nontraumatic neck pain). Participants were not allowed to continue other therapies, except for usual medication. Participants were asked not to start a new therapy or new medication 6 weeks before the trial and during study participation. Exclusion criteria were specific medical conditions (neuropathic pain, neck or back surgery in the prior 3 years, osteoporotic vertebral fractures, or rheumatologic diseases) or chronic widespread pain syndromes (fibromyalgia or chronic fatigue syndrome) and residence more than 50 km away from the hospital (to avoid dropping out of the trial). Sample size was calculated using G*Power software (Universität Düsseldorf) based on the effects on pain in the pilot study (partial η 2 = 0.02, α = .05, power = 0.80) and accounted for F tests and 30% loss to follow-up after 1 year, resulting in a total sample size of 117 individuals.
score considered clinically important. 14 The CSI assesses the presence of hypersensitivity by evaluating 25 symptoms that people with chronic pain might encounter (eg, sensitivity to light or concentration difficulties) on a 5-point Likert-scale (where 0 indicates that this symptom never occurs and 5 indicates that this symptom always occurs). 15 Pressure pain thresholds (ie, the point of minimum pressure that induces an unpleasant sensation) were determined using a digital pressure algometer with a 1-cm 2 tip (Wagner Instruments) at the most painful side or at the dominant side in case of bilateral pain. Pressure pain thresholds were randomly measured twice at the symptomatic sites (trapezius muscle midway between C7 and the acromion tip and 5 cm lateral of the spinous process of L3) and at the remote sites (quadriceps muscle and the web between the thumb and index finger). The CPM paradigm evaluates the descending nociceptive inhibition efficacy, using a cold-water bath (12°C; Versacool) for 2 minutes' immersion of the hand contralateral to the PPT measurements. After 30 seconds, PPTs were measured again. Initial PPTs were subtracted from PPTs during the cold pressor test. A negative value indicates an impaired inhibitory response (ie, lower PPT than before the cold pressor test). A positive value indicates an inhibitory response (ie, higher PPT than before the cold pressor test). Function was measured using the 36-Item Short Form Health Survey (SF36), 16 which evaluates health-related quality of life and is analyzed into 2 main domains (the physical and mental component), and the Pain Disability Index (PDI), which assesses the level of perceived disability due to pain during 7 daily-life activities, such as family and home responsibilities, recreation, and social activities. A decrease in PDI scores of 8.5 to 9.5 is considered to be clinically relevant.
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Secondary Outcome Measures
Gray matter morphologic features were evaluated using magnetic resonance imaging (Siemens; 32-channel radiofrequency head coil 
Intervention
Both interventions (duration, 12 weeks) comprised 3 educational sessions (group session, home-based online module, and individual session) and 15 one-on-one exercise sessions. The content of the therapy differed between groups (eTable 1 in Supplement 2). The experimental intervention combined pain neuroscience education with cognition-targeted motor control training. Pain neuroscience education aims to reconceptualize patients' beliefs about pain, to increase their knowledge of pain and to decrease its threat. The content included the following topics in nontechnical terms: the neuron, the synapse, descending nociceptive inhibition and facilitation, peripheral sensitization, and central sensitization. 23 The exercise program started with sensorimotor control training, adapted to comply with modern pain neuroscience using a time-contingent rather than pain-contingent approach (eTable 1 in Supplement 2) and aiming to change inappropriate beliefs and perceptions into correct ones. Simultaneously, movements that participants feared and avoided were introduced using a graded approach with increasing complexity (ie, progression toward physically, cognitively, and psychosocially demanding situations). The detailed treatment protocol is available elsewhere.
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The control intervention comprised current best-evidence physiotherapy, including traditional back and neck education and general exercises. 25, 26 The education covered the following topics: mechanical causes of back and neck pain; spine anatomy, physiology, and biomechanics; the importance of self-care and ergonomics; intradiscal pressure and joint forces; lifting techniques; and the value of stretching and strength, endurance, and fitness training. The pain-contingent exercise program focused on treating biomedical dysfunctions of the spine (ie, mobility, muscle strength, muscle endurance, and general fitness exercises), with an evolution toward functional activities and physically demanding tasks while keeping the spine in physiologically neutral positions. When the participant reported pain during or after an exercise, the intensity or duration of the exercise was reduced.
Statistical Analysis
All data were analyzed using SPSS, version 24.0 (SPSS Inc). Measurements of PPT and CPM at the primary body site (lower back and trapezius muscle) were taken together using body site as a covariate in the model. For each variable, the percentage of change compared with baseline was calculated. Effect sizes of the mean group differences were calculated as the Cohen d. To assess the difference between groups in response to treatment, a randomintercept linear mixed models analysis, using Bonferroni post hoc analyses, was applied with an unstructured covariance matrix. The model included treatment, time, and treatment × time as fixed effects together with a random intercept for each patient.
P < .05 (2-sided) was considered significant.
Results
A total of 120 people with nCSP were included in the trial and received pain neuroscience education combined with cognition-targeted motor control training (experimental treat-ment [n = 60]) or current best-evidence physiotherapy (control treatment [n = 60]) ( Figure) . The baseline characteristics of these participants are presented in Table 1 .
The primary outcome measures included pain and function ( Table 2 ; eFigures 1 and 2 in Supplement 2). Although the NRS did not show significant interaction effects, a significant main effect of time was found. Significant treatment × time interaction effects were found for primary site PPTs, the CSI, the PDI, and the SF36 mental and physical subscale. Post hoc tests showed larger improvements in the experimental group (small to medium effect sizes): lower CSI scores at 6 months (estimated marginal [EM] mean, -5.684; 95% CI, -10.589 to -0.780]) and 12 months (EM mean, -6.053; 95% CI, -10.781 to -1.324); lower PDI scores at 3 months (EM mean, -5.113; 95% CI, -9.994 to -0.232), 6 months (EM mean, -6.351; 95% CI, -11.153 to -1.550), and 12 months (-5 The secondary outcome measures included gray matter morphologic features and pain cognitions (Table 2; eTable 2 and eFigure3inSupplement 2) . No significant interaction effects or increased gray matter volumes at the subcortical level were found. Regarding the cortical regions of interest, the supramarginal gyrus showed an interaction effect. Bonferroni post hoc analysis showed that the experimental treatment led to a significantly higher supramarginal thickness at 3 months (EM mean, 0.046; 96% CI, 0.000-0.093; P = .049) and 12 months (EM mean, 0.049; 95% CI, 0.005-0.092; P = .03).
The Tampa Scale for Kinesiophobia and the Pain Vigilance and Awareness Questionnaire showed significant group × time interaction effects (Table 2) . Bonferroni post hoc analysis showed lower scores in the experimental group on the Tampa Scale for Kinesiophobia (medium to large effect size) at 3 months (EM mean, -8.680; 95% CI, -11.067 to -6.294), 6 months (EM mean, -9.810; -12.301 to -7.320), and 12 months of follow-up (EM mean, -8.862; 95% CI, -11.097 to -6.628) and on the Pain Vigilance and Awareness Questionnaire (medium to large effect size) at 3 months (EM mean, -8.265; 95% CI, -12.959 to -3.571), 6 months (EM mean, -7.269;95%CI,-12.294to-2.243),and12monthsoffollow-up (EM mean, -6.316; -11.070 to -1.561).
Discussion
Despite the inability to change gray matter morphologic features, pain neuroscience education combined with cognitiontargeted motor control training improved pressure pain sensitivity, central sensitization symptoms, mental and physical functioning, kinesiophobia, and hypervigilance and reduced disability in patients with nCSP. These effects were of clinical importance (medium to large effect sizes and 50% improvement in pain) and were maintained at long-term follow-up.
Primary Outcomes: Pain and Function
Despite the absence of treatment differences, only the experimental group showed an increase in PPTs of more than 15% (an increase of >1.5 kg/cm 2 at the primary test site), which is considered to be clinically relevant. 27 Also, although the decrease in NRS pain scores exceeded the minimal clinically important difference (ie, 30%) in both groups, 14 percentage changes and effect sizes were considerably higher in the experimental group (42.79%-52.22% reduction) compared with the control group (23.58%-33.13% reduction). Lastly, the experimental group showed significantly lower CSI scores after treatment (medium effect sizes) than the control group. These significant changes in CSI scores and the clinical interpretation of the PPTs and the NRS (medium to large effect sizes and/or clinically important changes) demonstrate the superiority of pain neuroscience education combined with cognitiontargeted motor control training compared with current bestevidence physiotherapy for individuals with nCSP at reducing pain. Although, to our knowledge, no previous studies have evaluated pain neuroscience education combined with cognitiontargeted motor control training, studies evaluating pain neuroscience education alone report small effect sizes. 28 The larger effect sizes presented here (in the short term and long term) are likely the result of integrating the newly derived pain neuroscience understanding in specific fearful movements and activities, enabling patients to deal with pain in daily life. Although the statistical and/or clinically relevant changes in these pain parameters support the effectiveness of the experimental intervention, we did not find any effect on the efficacy of CPM. The CPM paradigm evaluates the descending nociceptive inhibitory systems, and previous research has reported less efficacious CPM in people with chronic spinal pain compared with healthy pain-free controls. 29, 30 Still, there is no association between CPM and the intensity of chronic pain, 31 and reduced CPM has been found in healthy individuals prior to the development of chronic neck pain. 32 Together with the results of our present study, these observations question the clinical importance of the CPM paradigm for people with nCSP, which could explain why the CPM parameter did not change while other pain parameters improved in response to the experimental treatment. For perceived pain disability and mental and physical health, the experimental group showed greater improvement compared with current best-evidence physiotherapy (small to medium effect sizes). This outcome is in line with a pilot study for individuals with chronic low back pain. 10 Again, these positive effects can be attributed to the content of the experimental treatment as participants learn to put pain into the right perspective, to move regularly, and to be physically active. Consequently, participants probably feel empowered, whereas, previously, they viewed pain was as a life-controlling factor. compared patients before and after therapy with healthy individuals at baseline, whereas our study is unique in evaluating brain morphologic features using a randomized clinical design with 2 different therapies. Taking into account the significant clinical reduction in pain and improvement in function in response to pain neuroscience education combined with cognition-targeted motor control training, we believe that these findings at the brain level question the previously reported brain changes in response to therapy in uncontrolled studies.
Regarding kinesiophobia, the experimental treatment showed larger reductions than current best-evidence physiotherapy. Whereas both groups showed baseline Tampa Scale for Kinesiophobia scores around the cutoff to indicate kinesiophobia, only the experimental group showed decreases exceeding the minimally important change of 5.5 (large effect sizes). 36 Similarly, hypervigilance improved more in the experimental group (medium to large effect sizes) than in the control group. Again, the combination of pain neuroscience education with cognition-targeted exercises reveals its added value, as previous research indicates that pain neuroscience education alone did not significantly reduce hypervigilance.
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No effect was seen for pain catastrophizing, although we expected a greater decrease in the experimental group. Combining pain neuroscience education with cognition-targeted motor control training stimulates people to put pain into the right perspective, to understand the pain problem, to increase functionality, and to use physical activity to positively influence symptoms. 10, 38 However, our results imply that this approach is not better than current best-evidence physiotherapy to reduce pain catastrophizing. Still, there was a reduction of 46.50% (3 months' followup) to 63.40% (12 months' follow-up) in the experimental group, whereas the control group showed reductions of 25.84% (3 months' follow-up) to 43.69% (12 months' follow-up) ( Table 2) .
Practical Implications and Recommendations for Research
Our results emphasize the need for a shift from a biomedical approach toward a biopsychosocial approach that combines pain neuroscience education with cognition-targeted motor control training for people with nCSP. Clinicians should integrate modern pain neuroscience into the management of nCSP, rather than focusing on a possible biomedical origin of pain.
However, because this study included people only with nCSP, other populations require study to see if these results can be generalized to a broad population with chronic pain. Further research should investigate if the combination of pain neuroscience education with cognition-targeted exercises is also effective in subgroups, such as individuals with chronic whiplash-associated disorders, and other populations with chronic pain, such as chronic knee osteoarthritis and postcancer pain. In addition, future research should focus on other brain imaging techniques, such as white matter properties, and functional connectivity analyses.
Limitations and Strengths
This study has some limitations. Statistical analyses were not corrected for hormonal influences, which may affect pain and other outcome measures, but it is still unclear what the hormonal effectsonpainintensityare.
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This study also has several strengths. To our knowledge, this is the first experimental study examining the possible treatment effects on brain morphologic features in people with nCSP. Likewise, to our knowledge, this is the first triple-blind, adequately controlled randomized clinical trial examining the effectiveness of pain neuroscience education combined with cognition-targeted motor control training for people with nCSP. This multicenter study was carried out using a large sample and exhibited substantial improvements and corresponding effect sizes among measures of pain, function, and psychosocial correlates. The trial compared balanced treatment arms, was sufficiently powered, used current best-evidence physiotherapy as the control intervention, relied on a published trial and treatment protocol, 12,24 and applied blinded outcomes assessments up to 1 year after treatment.
Conclusions
Combining pain neuroscience education with cognition-targeted exercises does not affect brain gray matter morphologic features but can reduce pain and disability and improve mental and physical functioning and pain cognitions in people with nCSP (clinically important results, long-term benefits, medium to large effect sizes, and 50% improvement in self-reported pain). The presence of significant clinical improvements without changes at the brain level challenges the clinical relevance of these alterations in gray matter morphologic findings in people with nCSP. This finding emphasizes the need for a shift toward a biopsychosocial focus (ie, cognition and perceptions underlying the pain problem), rather than maintaining a focus toward a purely biomedical origin when treating these patients in clinical practice. pressure pain thresholds (PPTs) and conditioned pain modulation) compared to usual care evidence based physiotherapy 3. Effect of a modern neuroscience approach on functioning compared to usual care evidence based physiotherapy 4. Effect of a modern neuroscience approach on brain gray matter structure compared to usual care evidence based physiotherapy 5.
Design
A 12 month multi center, triple blind, randomized, controlled, parallel group trial. Patients with CSP (including low back and neck pain, failed back surgery and chronic whiplash associated disorders) will be enrolled in a structured 3 month rehabilitation program organized in University Hospital Brussels and Ghent University Hospital. More specifically, therapeutic pain neuroscience education combined with cognition targeted exercise therapy will be compared to back/neck school and general exercises. Treatment outcomes will be assessed at baseline, after 3 treatment sessions, post treatment (at 3 months), at 6 months and 1 year follow up (Figure 1 ). Following the go/no go principle, however, the 1 year follow up examination will not take place in case that treatment effects are no longer present at 6 months follow up in none of the treatment arms.
Study population
This study will include 120 CSP patients. Patients will be recruited from the hospital, from primary care practices (medical doctors) and via adverts. Inclusion criteria are: Dutch speaking male and female adult (aged 18 -65 years) patients seeking care for non specific CSP (at least 3 days/week) for at least 3 months, not starting new treatments or medication and continuing usual care 6 weeks prior to and during study participation (to obtain a steady state). Patients will be excluded in case of: neuropathic pain, chronic widespread pain according to the 1990 ACR criteria, a history of back or neck surgery in the past 3 years, a lifetime history of specific back or neck surgery (e.g. surgery for spinal stenosis) or osteoporotic vertebral fractures, rheumatologic diseases, concomitant therapies (i.e., rehabilitation, alternative medicine or therapies), medical conditions or contra indications for MRI, pregnancy in the last year before enrolment, and people living or working outside a 50km radius of the treatment locations. Study participants will be asked to refrain from analgesics 48 h prior to assessments, to abstain from caffeine, alcohol and nicotine in the 3 days before assessment.
Randomization
Participants will be randomized to either control or experimental group (1:1 ratio) using a stratified permuted block allocation with stratification factors being treatment center (Brussels or Ghent), gender (male or female) and dominant pain location (low back or neck) and with a block size of four. Randomization will be done by an independent investigator at the Biostatistics Unit (Ghent University) using the SAS version 9.4 package. The randomization schedule will be known only to 1 investigator who is not involved in patient recruitment.
Blinding
The randomization will be concealed from patients and the other investigators involved in patient assessments and analyses.
Outcome measures
1. Primary outcome measures a. A Numerical Rating Scale (NRS) for pain ranging from 0 = "no pain" to 10 = "the worst pain imaginable" ("How would you rate your spinal pain, on average, over the last three days?") b. The Central Sensitization Inventory (CSI) assessing current health symptoms indicative of central sensitization in 25 statements; on a Likert scale from 0 (never) to 4 (always), resulting in a total possible score of 100; higher scores are associated with a higher degree of self reported symptomology c. The Short Form Health Survey -36 item (SF 36) will be used to assess self reported metal and physical health. d. Pressure Pain Thresholds will be assessed using a digital Wagner algometer (Wagner Instruments, Greenwich, CT). at the symptomatic levels (the upper trapezius muscle midway between C7 and the tip of the acromion and 5 cm lateral of the spinous process of L3) and at remote sites (quadriceps muscle and the web between thumb and index finger). The pressure will be increased at a constant rate of 1 kg/m2/s. PPTs will be tested unilaterally at the most painful side will be assessed unless the pain is evenly distributed on both sides. Then, the dominant side will be investigated. At each of the selected measuring points, the threshold will be determined as the mean of 2 consecutive (30 s in between) measurements. e. Conditioned Pain Modulation will evaluate the efficacy of the descending inhibitory modulation of pain (i.e. conditioned pain modulation) using the immersion of the hand in a cold water bath (12 degrees Celsius) for 2 minutes. Before and during submersion, the pressure pain thresholds will be measured on several body sites using pressure algometry (see above). Subjects will be asked to rate the perceived pain intensity on an 11 point visual numeric rating scale. f. The Pain Disability Index will be used to rate perceived disability due to pain.
Secondary outcome measures
a. Brain gray matter structure will be measured using high resolution magnetic resonance imaging (Siemens medical solutions, Erlangen, Germany). A T1 weighted structural MRI will be acquired by using a 3D FLASH sequence (repetition time 2250 ms, echo time 4.18 ms, flip angle 9°, field of view 256 × 256; 176 slices), acquisition time 05 14 . Regional gray matter density will be assessed with voxel based morphometry that allows for applying voxelwise statistics to detect regional differences in gray matter volumes. Preprocessing will be performed using Freesurfer and will involve spatial normalization, gray matter segmentation, and 10 mm spatial smoothing with a Gaussian kernel. b. Motor control:
i. Postural steadiness will be characterized by postural sway features as measured by an AccuGait portable forceplate (50 cm × 50 cm) (Advanced Medical Technology, Inc. Watertown, MA) during bipedal standing with eyes closed on a firm surface. ii. For the assessment of habitual standing posture in the sagittal plane, the orientation of gross body segments with respect to the vertical will be quantified using posthoc analyses of digitized photographs of participants. iii. Range of motion of the cervical spine (flexion, extension, lateral flexion) will be measured in neck pain patients (seated position) using the Acumar™ digital inclinometer (Model ACU 360, Lafayette Instrument Company, Lafayette, IN) that is placed on the vertex of the head through T1. iv. Lumbar lateral flexion will be measured using the Acumar™ digital inclinometer (see above) placed on T12 through S1. v. Proprioception will be determined by evaluating the position reposition accuracy of the spine. In neck pain patients, repositioning will be assessed by the cervicocephalic relocation test to the neutral head position with eyes closed. vi. Neuromuscular control will be assessed as the patients' ability to perform the skill of activation of specific, deep stabilizing muscles for which there is scientific evidence that they play a crucial role in spinal stability. In neck pain patients, the contraction of the deep neck flexors will be evaluated through the craniocervical flexion test and the lower and middle trapezius muscles will be assessed via the scapular holding test/scapula setting. In low back pain patients, multifidus and transverse abdominis contraction will be evaluated in prone and supine (drawing in action), respectively. c. Muscle properties:
i. isometric muscle strength will be measures using a hand held dynamometer. In neck pain patients, the testing procedure will consist of seated isometric strength measures for neck flexion, extension and side bending (left and right). In patients with dominant low back pain, trunk flexor and extensor muscle strength will be evaluated.
ii. Muscle endurance will be assessed using isometric tests, i.e. patients will be instructed to maintain an imposed posture as long as possible. In neck pain patients, endurance of the neck flexors will be evaluated with the deep neck flexor endurance test. Low back pain patients will perform a trunk flexor and extensor endurance test. d. Psychosocial correlates i. The Pain Catastrophizing Scale will be included to assess catastrophic thinking about pain. It consists of 13 items describing different thoughts and feelings that individuals may have when experiencing pain. ii. The Pain Vigilance and Awareness Questionnaire will be used to investigate patients' attention to pain. iii. The Tampa Scale for Kinesiophobia (TSK) is a 17 item questionnaire that will be used to measure the fear of (re) injury due to movement iv. The Illness Perception Questionnaire Revised consists of 3 domains and will be used to measure patients' illness perceptions.
Interventions
Experimental intervention
Patients will participate in an initial group session (maximum 6 persons/group) of pain neuroscience education that will last about 1 hour and includes the possibility for patients to ask questions during the session. After this first session, the patient is sent home with an information leaflet as refresher and for informing the significant other. Furthermore, the patient is asked to complete the "feared activity form", a clinical tool that assesses which activities could worsen complaints and cause damage according to the patient. The next session is an online module performed at home. The content is comparable, but also the role of stress is explained. The online module consists of movies, interrupted by online questioning. The last session is a 30' individual session addressing specific questions and translating the content to the daily life of the patient. Perceptions are questioned again, goals are discussed and therapeutic alliance is checked. The content, format and pictures of the educational sessions are based on the book 'Explain Pain' and 'Pijneducatie een praktische handleiding voor (para)medici'. We will present the educational information verbally (explanation by the therapist) and visually (summaries, pictures, metaphors and diagrams on computer and paper). A more detailed description on the organization of the education is also provided in our masterclass guideline. The education covers the physiology of the nervous system in general and of the pain system in particular. Topics addressed during the educational sessions will include the characteristics of acute versus chronic pain; how pain becomes chronic (plasticity of the nervous system, modulation, modification, central sensitization, etc.); potential sustaining factors of central sensitization like emotions, stress, pain cognitions, and pain behaviour; etc. Level A evidence supports the use of pain neuroscience education for chronic musculoskeletal disorders in reducing pain and improving patient knowledge of pain, improving function and lowering disability, reducing psychosocial factors, enhancing movement, and minimizing healthcare utilization.
Once adaptive beliefs are acquired regarding CSP a further time contingent, cognition targeted approach to daily (physical) activity and exercise therapy. Cognition targeted exercise therapy comprises two main phases: cognition targeted motor control training and cognition targeted dynamic and functional exercises. Important is the time contingent approach, the continuous targeting of cognitions and perceptions about their problems and the outcome of each exercise and the gradual progression to more feared movements and activities. The specific content of the exercises is tailored based on the "feared activity form".
PHASE A: COGNITION TARGETED MOTOR CONTROL TRAINING This phase consists of a proprioception, coordination, and sensorimotor control training program based on the principles and ideas of researchers and clinicians such as, Sahrmann, Comerford and Mottram, and Richardson and Jull, adapted to comply with modern pain neuroscience and thus providing the CSP patient a cognition targeted approach. In neck pain patients, this phase of the exercise will involve retraining of the deep cervical flexors/extensors and scapular muscles, whereas retraining of the deep muscles surrounding the lumbopelvic region (e.g., multifidus, transversus abdominis, psoas, pelvic floor muscles) will be performed in patients with low back pain.
Crucial again is the method of delivering these types of exercises to the patient within the modern neuroscience framework, which will be mostly depending on communication techniques that should be aligned with the content of the pain neuroscience education: exercise as brain therapy rather than a modality to correct biomechanical deficits.
PHASE B: COGNITION TARGETED DYNAMIC AND FUNCTIONAL EXERCISES
The purpose of this phase is to confront the patient with movements and activities that are feared, avoided and/or painful. During the physiotherapy sessions, home exercises and in daily life it is crucial to avoid all 'safety behaviour' and to focus on normal and functional movements. This phase involves increasing the complexity of exercises. Progression is targeted and developed towards those movements and activities the patient is fearful of (e.g. bending forward in chronic low back pain, or neck extension in chronic neck pain patients). All exercises, movements and activities used in the cognition targeted exercise training can be implemented in the home program. Throughout the cognition targeted motor control training program, patients' cognitions and perceptions about their problem and about exercises will be addressed.
Control intervention
The control group will receive traditional back/ neck school, including back care education and general exercises. Back care education will cover anatomy and biomechanics of the spine, common causes of spinal pain, the load tolerance model, nociceptive pain processing, and ergonomic counseling based on the inherent postural strain associated with various postures and daily activities (including standing, sitting, and lifting). As such, the education sessions will prepare the patients for a symptom contingent, biomedical approach to daily (physical) activity and exercise therapy. In session 4, the general exercise therapy will be started with specific emphasis on treating dysfunctional muscles and joints. Different therapeutic goals will be pursued (e.g. microcirculation, mobility, endurance, strength) depending on what emerges from the clinical reasoning as the most dominant peripheral dysfunction. The program will also involve aerobic fitness improving exercises. The progressive exercise program will mainly entail an increase in exercise intensity, and an evolution towards functional activities and more physically demanding tasks while keeping the spine in physiological neutral positions to minimize strain imposed upon the spinal structures. All exercises will be performed in a symptom contingent way.
Sample size calculation
Sample size was calculated using G*Power software based on partial eta squared = 0.02, alpha = .05 and a power of 0.80; and accounted for F tests and 30% loss to follow up after 1 year, resulting in a total ample size of 117 individuals.
Ethics
This trial will be conducted in compliance with the Declaration of Helsinki (1964 and amendments) and Good Clinical Practices. Patients will give their written informed consent prior to the start of any study related procedure. Approval to conduct this study was granted by the Ethics Committee of the Ghent University Hospital and the University Hospital Brussels. Other: Therapeutic §! Aim of the experiment (in some sentences):
S
A Randomized Trial of Pain Neuroscience Education
The main scientific aim of this study is to investigate the effectiveness of a modern neuroscience approach in patients with chronic spinal pain (experimental group) compared to traditional, evidence-based physiotherapy. The primary outcome measures include pain (NRS, CSI, PPTs) and disability (PDI and SF36). §! Summary of the project (in some sentences):
120 Dutch-speaking patients with chronic spinal pain (CSP) will be recruted through firstline healthcare, the department of medical supervision at the VUB and the UGent, companies near Ghent and Brussels, and the media. These patients will be randomised into the experimental and control group. The study design entails a randomised, trippleblind controlled trial.
Short description of the outcome measures:
-! Baseline evaluation of 120 CSP patients: online questionnaires on pain (inclusive of symptoms of central sensitization), the impact of pain on daily functioning, and painrelated psychological variables (pain catastrophizing, pain attention, fear of movement, illness perceptions. Also, pressure pain thresholds and conditioned pain modulation will be determined using pressure algometry (combined with a cold water bath for conditioned pain modulation measurement). Body position will be evaluated using 2D digital photography with post-hoc angel measurements on the photos. Balance will be determined using the accugait and muscle properties and motor control will be evaluated using clinical tests. Last, MRI will be used to evaluate gray matter volume and the white matter integrity.
Filling out the online questionnaires will take about 30 minutes. During a first test moment, all other outcome measures will be tested (duration: max 1h), except for the MRI, which will be done during a second test moment (duration: max 1.5h). After three therapy sessions, these will be a small re-evaluation: PCS, PVAQ, TSK, IPR and PDI (online questionnaires). Also, the Neurophysiology of pain questionnaire will be filled out online: duration 30 min. In the month after the last therapy session (i.e. session 18, 3 months after baseline assessment) the short-term treatment effects will be studied: all baseline tests are repeated. Therapy sessions will take place in the University Hospitals of Ghent or Brussels, depending on the preference of the patient. All sessions will be deliverend within three months.
Outcome assessors will be blinded for the randomization sequence. Other researchers will deliver the treatment. The participants will not be aware of the treatment group that they are in. 
